![](https://pharmaphorum.com/sites/default/files/2024-07/national-cancer-institute-unsplash.jpg)
Study finds GLP-1 drugs may cut obesity-related cancers
Potentially adding to a lengthening list of positive health benefits of GLP-1 agonist drugs, a new study has suggested they may also reduce the risk of a bevy of cancers associated with being very overweight. The retrospective analysis published in JAMA …